IRCT2015112125171N1已完成1 期
The study of the safety and effect of high dose allopurinol on the clinical, laboratory and echocardiographic variables in patients with severe left ventricle systolic dysfunction
Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran0 个研究点目标入组 30 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 80 years（—）
- 性别
- All
入选标准
- •Age of 18-80 years old; severe left ventricle systolic dysfunction (Ejection fraction of less than 35%) on optimal medical treatment for at least one month with New York heart association functional class of II-III; having informed written consent.
- •Exclusion criteria: Below the age of 18 and above the age of 80 years old; glomerular filtration rate of less than 60ml/min; serum creatinine level of more than 3mg/dl; severe hepatic failure; use of azathioprin; use of 6mercaptopurin; use of warfarin; known history of sensitivity to allopurinol.
排除标准
- 未提供
研究者
相似试验
已完成
不适用
Safety evaluation studies of high dose intake of a food aiming for official recognition as a Food with Function Claims.Healthy volunteersJPRN-UMIN000035164Kochi University12
已完成
不适用
Investigation for efficacy and safety of high dose chemotherapy (MEAM) supported with auto-PBSCT for malignant lymphoma (THF 13)Malignant lymphomaJPRN-UMIN000002743TOHOKU HEMATOLOGY FORUM30
已完成
不适用
Safety evaluation studies of high dose intake of capsules including herb extractHealthy adultJPRN-UMIN000028987TTC Co., Ltd.10
已完成
不适用
Safety evaluation studies of high-dose ingestion of mangosteen soft capsuleJPRN-UMIN000023284TTC Co., Ltd.10
进行中（未招募）
1 期
Feasibility study to assess safety of high dose of lanreotide in net patients poorly controlled by standard doses of SSAeuroendocrine tumoursMedDRA version: 14.1Level: PTClassification code 10052399Term: Neuroendocrine tumourSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2012-005222-30-ITIVERSITA' DI GENOVA